alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › amyloid-peptide

amyloid-peptide

6 studies tagged amyloid-peptide, dated 2011-03-03 to 2025-03-13. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Ganglioside lipids inhibit the aggregation of the Alzheimer's amyloid-β peptide 2025-03-13
  2. New Insights into the Spontaneous Human Alzheimer's Disease-Like Model Octodon degus: Unraveling Amyloid-β Peptide Aggregation and Age-Related Amyloid Pathology 2018-01-01
  3. Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study 2017-01-01

Studies

6 studies carry this tag.

Date range

2011 to 2025

Top journals

  • Journal of Alzheimer's disease : JAD 4
  • Experimental gerontology 1
  • RSC chemical biology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Ganglioside lipids inhibit the aggregation of the Alzheimer's amyloid-β peptide

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. RSC chemical biology 2025-03-13 Biomarkers

    The aggregation of the amyloid-β (Aβ) peptides (Aβ42/Aβ40) into amyloid fibrils and plaques is one of the molecular hallmarks in dementia and Alzheimer's disease (AD).

  2. New Insights into the Spontaneous Human Alzheimer's Disease-Like Model Octodon degus: Unraveling Amyloid-β Peptide Aggregation and Age-Related Amyloid Pathology

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Journal of Alzheimer's disease : JAD 2018-01-01 Biomarkers

    Alzheimer's disease (AD) is the most common cause of dementia worldwide.

  3. Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Journal of Alzheimer's disease : JAD 2017-01-01 Biomarkers

    Type 2 diabetes is associated with altered plasma concentrations of Aβ peptides and is an important source of variation that needs to be taken into account when considering plasma Aβ peptides as biomarkers for Alzheimer's disease.

  4. Serum NGAL is Associated with Distinct Plasma Amyloid-β Peptides According to the Clinical Diagnosis of Dementia in Down Syndrome

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Journal of Alzheimer's disease : JAD 2015-01-01 Biomarkers

    Serum NGAL levels are increased in DS and associated with distinct species of Aβ depending on the progression of dementia as diagnosed by baseline and follow-up clinical assessments.

  5. Age-related changes in brain extracellular space affect processing of amyloid-β peptides in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of Alzheimer's disease : JAD 2013-01-01 Biomarkers

    Alzheimer's disease is a neurodegenerative disease in which aging is not only a major risk factor but a major determinant of onset, course, and pathogenesis.

  6. Plasma β-amyloid peptides in canine aging and cognitive dysfunction as a model of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Experimental gerontology 2011-03-03 Biomarkers

    Aging dogs naturally demonstrate cognitive impairment and neuropathology that model early Alzheimer's disease (AD).

All topic tags with their study counts